A Malaysian expert (C) examines a black box belonging to Malaysia Airlines flight MH17 during its handover from pro-Russian separatists, in Donetsk.

European stocks rebounded on Tuesday with traders hoping for an easing of tensions between Russian and the West after pro-Russian rebels agreed to han(...)

A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange on Friday. Photograph: Reuters

AbbVie defended plans to shift its tax residence to the UK after agreeing to buy Shire for £32 billion and urged US politicians to consider comprehens(...)

Tablets of Shire’s Adderall. Abbvie is paying about £52.48 per share for Shire. Photo: Bloomberg

US drugmaker AbbVie bought Dublin-based Shire on Friday in a $53 billion-pound deal that will allow it to slash its tax bill by relocating to Britain.(...)

Stocktake

One person expecting a bear market is Marc “Dr Doom” Faber, who last week warned that the S&P 500 was facing a 30 per cent drop. Faber famo(...)

The latest proposal is AbbVie’s fifth attempt to lure Shire into a takeover since the courtship began in May. Photograph: Simon Dawson/Bloomberg

Shire has opened the door to a takeover by US pharmaceuticals rival AbbVie after saying its board would be willing to recommend a £31 billion cash and(...)

Adderall XR, one of Shire’s treatments for attention deficit hyperactivity disorder. AbbVie is eager to acquire Irish drug maker Shire, which would allow it to reincorporate in Britain and save millions on taxes, but Shire has yet to approach the negotiating table. Photograph: Elizabeth D. Herman/The New York Times

AbbVie wants a new legal home with a lower tax rate. To make the move, the drugmaker may have to raise its offer for Shire yet again. AbbVie, the Nor(...)

Online grocery group Ocado is set to make its first annual profit since being set up by three former Goldman Sachs bankers in 2000.

It’s taken almost a decade and a half but, at last, online grocery group Ocado is set to make its first annual profit since being set up by three form(...)

 AbbVie, in its pursuit of drugmaker Shire, has hired some of the same advisers that Pfizer worked with in its failed push for AstraZeneca. Photo: Bloomberg

AbbVie, in its pursuit of drugmaker Shire, has hired some of the same advisers that Pfizer worked with in its failed push for AstraZeneca. Richard G(...)

Richard Pops, Alkermes chief executive, says that the company is not interested in being bought out as it nears the launch of new drugs.Photograph: Dara Mac Dónaill / THE IRISH TIMES

Dublin-based Alkermes has the low-tax domicile currently in vogue among multinational pharmaceutical companies but is not interested in being bought o(...)

Founded in 1986 in Britain, Shire conducts most of its business in the United States and has been domiciled in Ireland for tax purposes since 2008. Photograph: JB Reed/Bloomberg News

US drugmaker AbbVie Inc has confirmed today that it had made a bid approach to Shire , which was rejected by the British group’s board. It said talks (...)